Literature DB >> 17082314

Progressive immunoglobulin gene mutations in chronic lymphocytic leukemia: evidence for antigen-driven intraclonal diversification.

Alicia D Volkheimer1, J Brice Weinberg, Bethany E Beasley, John F Whitesides, Jon P Gockerman, Joseph O Moore, Garnett Kelsoe, Barbara K Goodman, Marc C Levesque.   

Abstract

Somatic mutations of immunoglobulin genes characterize mature memory B cells, and intraclonal B-cell diversification is typically associated with expansion of B-cell clones with greater affinity for antigen (antigen drive). Evidence for a role of antigen in progression of intraclonal chronic lymphocytic leukemia (CLL) cell diversification in patients with mutated immunoglobulin genes has not been previously presented. We performed a single-cell analysis of immunoglobulin heavy and light chains in 6 patients with somatically mutated CLL-cell immunoglobulin genes and identified 2 patients with multiple related (oligoclonal) subgroups of CLL cells. We constructed genealogic trees of these oligoclonal CLL-cell subgroups and assessed the effects of immunoglobulin somatic mutations on the ratios of replacement and silent amino acid changes in the framework and antigen-binding regions (CDRs) of the immunoglobulin heavy and light chains from each oligoclonal CLL-cell population. In one subject, the amino acid changes were consistent with an antigen-driven progression of clonally related CLL-cell populations. In the other subject, intraclonal diversification was associated with immunoglobulin amino acid changes that would have likely lessened antigen affinity. Taken together, these studies support the hypothesis that in some CLL cases intraclonal diversification is dependent on antigen interactions with immunoglobulin receptors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17082314      PMCID: PMC1794047          DOI: 10.1182/blood-2006-05-020644

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  45 in total

Review 1.  The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire.

Authors:  H W Schroeder; G Dighiero
Journal:  Immunol Today       Date:  1994-06

2.  Evidence for immunoglobulin heavy chain variable region gene replacement in a patient with B cell chronic lymphocytic leukemia.

Authors:  K Stamatopoulos; C Kosmas; N Stavroyianni; D Loukopoulos
Journal:  Leukemia       Date:  1996-09       Impact factor: 11.528

3.  National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment.

Authors:  B D Cheson; J M Bennett; M Grever; N Kay; M J Keating; S O'Brien; K R Rai
Journal:  Blood       Date:  1996-06-15       Impact factor: 22.113

4.  Lack of intraclonal diversification in Ig heavy and light chain V region genes expressed by CD5+IgM+ chronic lymphocytic leukemia B cells: a multiple time point analysis.

Authors:  E W Schettino; A Cerutti; N Chiorazzi; P Casali
Journal:  J Immunol       Date:  1998-01-15       Impact factor: 5.422

5.  Molecular mechanisms and selective influences that shape the kappa gene repertoire of IgM+ B cells.

Authors:  S J Foster; H P Brezinschek; R I Brezinschek; P E Lipsky
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

6.  Evidence for progenitors of chronic lymphocytic leukemia B cells that undergo intraclonal differentiation and diversification.

Authors:  M Dono; S Hashimoto; F Fais; V Trejo; S L Allen; S M Lichtman; P Schulman; V P Vinciguerra; B Sellars; P K Gregersen; M Ferrarini; N Chiorazzi
Journal:  Blood       Date:  1996-02-15       Impact factor: 22.113

7.  Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

Authors:  R N Damle; T Wasil; F Fais; F Ghiotto; A Valetto; S L Allen; A Buchbinder; D Budman; K Dittmar; J Kolitz; S M Lichtman; P Schulman; V P Vinciguerra; K R Rai; M Ferrarini; N Chiorazzi
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

8.  Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features.

Authors:  T A Johnson; L Z Rassenti; T J Kipps
Journal:  J Immunol       Date:  1997-01-01       Impact factor: 5.422

9.  Molecular analysis of rearranged VH genes during B cell chronic lymphocytic leukemia: intraclonal stability is frequent but not constant.

Authors:  A S Korganow; T Martin; J C Weber; B Lioure; P Lutz; A M Knapp; J L Pasquali
Journal:  Leuk Lymphoma       Date:  1994-06

10.  Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.

Authors:  F Fais; F Ghiotto; S Hashimoto; B Sellars; A Valetto; S L Allen; P Schulman; V P Vinciguerra; K Rai; L Z Rassenti; T J Kipps; G Dighiero; H W Schroeder; M Ferrarini; N Chiorazzi
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

View more
  14 in total

Review 1.  Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities.

Authors:  Nicholas Chiorazzi; Manlio Ferrarini
Journal:  Blood       Date:  2010-12-09       Impact factor: 22.113

Review 2.  Immunologic aspects of monoclonal B-cell lymphocytosis.

Authors:  Mark C Lanasa; J Brice Weinberg
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

3.  Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function.

Authors:  D J DiLillo; J B Weinberg; A Yoshizaki; M Horikawa; J M Bryant; Y Iwata; T Matsushita; K M Matta; Y Chen; G M Venturi; G Russo; J P Gockerman; J O Moore; L F Diehl; A D Volkheimer; D R Friedman; M C Lanasa; R P Hall; T F Tedder
Journal:  Leukemia       Date:  2012-07-13       Impact factor: 11.528

4.  A method for the isolation and characterization of functional murine monoclonal antibodies by single B cell cloning.

Authors:  Sara Carbonetti; Brian G Oliver; Vladimir Vigdorovich; Nicholas Dambrauskas; Brandon Sack; Emilee Bergl; Stefan H I Kappe; D Noah Sather
Journal:  J Immunol Methods       Date:  2017-05-26       Impact factor: 2.303

5.  Intraclonal cell expansion and selection driven by B cell receptor in chronic lymphocytic leukemia.

Authors:  Monica Colombo; Giovanna Cutrona; Daniele Reverberi; Sonia Fabris; Antonino Neri; Marina Fabbi; Giovanni Quintana; Giovanni Quarta; Fabio Ghiotto; Franco Fais; Manlio Ferrarini
Journal:  Mol Med       Date:  2011-04-28       Impact factor: 6.354

6.  High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies.

Authors:  Hua-Xin Liao; Marc C Levesque; Ashleigh Nagel; Ashlyn Dixon; Ruijun Zhang; Emmanuel Walter; Robert Parks; John Whitesides; Dawn J Marshall; Kwan-Ki Hwang; Yi Yang; Xi Chen; Feng Gao; Supriya Munshaw; Thomas B Kepler; Thomas Denny; M Anthony Moody; Barton F Haynes
Journal:  J Virol Methods       Date:  2009-02-21       Impact factor: 2.014

7.  Patterns of microRNA expression characterize stages of human B-cell differentiation.

Authors:  Jenny Zhang; Dereje D Jima; Cassandra Jacobs; Randy Fischer; Eva Gottwein; Grace Huang; Patricia L Lugar; Anand S Lagoo; David A Rizzieri; Daphne R Friedman; J Brice Weinberg; Peter E Lipsky; Sandeep S Dave
Journal:  Blood       Date:  2009-02-06       Impact factor: 22.113

8.  Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing.

Authors:  Peter J Campbell; Erin D Pleasance; Philip J Stephens; Ed Dicks; Richard Rance; Ian Goodhead; George A Follows; Anthony R Green; P Andy Futreal; Michael R Stratton
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-22       Impact factor: 11.205

9.  Single-cell analysis reveals oligoclonality among 'low-count' monoclonal B-cell lymphocytosis.

Authors:  M C Lanasa; S D Allgood; A D Volkheimer; J P Gockerman; J F Whitesides; B K Goodman; J O Moore; J B Weinberg; M C Levesque
Journal:  Leukemia       Date:  2009-10-15       Impact factor: 11.528

Review 10.  AID in Chronic Lymphocytic Leukemia: Induction and Action During Disease Progression.

Authors:  Pablo Oppezzo; Marcelo Navarrete; Nicholas Chiorazzi
Journal:  Front Oncol       Date:  2021-05-10       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.